摘要
目的:探讨对耐多药肺结核患者采用含左氧氟沙星与含莫西沙星方案治疗的临床疗效。方法:收治耐多药肺结核患者76例,随机分成两组,各38例,分别采用含左氧氟沙星与含莫西沙星方案治疗。结果:含左氧氟沙星组总有效率94.7%,含莫西沙星组97.4%,差异无统计学意义(P>0.05)。结论:含左氧氟沙星与含莫西沙星方案治疗耐多药肺结核患者均有较好的疗效。
Objective:To investigate the clinical efficacy of levofloxacin and moxifloxacin in the treatment of patients with multi drug resistant pulmonary tuberculosis.Methods:76patients with multi drug resistant pulmonary tuberculosis were selected.They were randomly divided into two groups with3roup.Then levofloxacin and moxifloxacin were used in the two groups respectively.Results:The total effective rate of levofloxacin group was94.7%,and the moxifloxacin group was97.4%.The difference was not statistically significant(P>0.05).Conclusion:Both levofloxacin and moxifloxacin containing regimens have better curative effect in the treatment of patients with multi drug resistant pulmonary tuberculosis.
作者
代春玲
廖爱华
Dai Chunling;Liao Aihua(Department of Respiration,the Sixth Affiliated Hospital of Xinjiang Production and Construction Corps 831300)
出处
《中国社区医师》
2017年第15期39-40,共2页
Chinese Community Doctors
关键词
含左氧氟沙星
含莫西沙星
耐多药肺结核
Levofloxacin
Moxifloxacin
Multi drug resistant pulmonary tuberculosis
